A comprehensive and systematic study will be undertaken to define the therapeutic utility of the hormone-like T cell growth-promoting lymphokine Interleukin-2 (IL-2) for the treatment of cancer using as a tumor model a unique mouse mammary adenocarcinoma designated as MC1. When compared to other mouse tumor models, the MC1 offers a number of advantages for defining in vivo IL 2-mediated immunomodulation of host-resistance to tumor progression. The MC1 tumor is a spontaneously arising neoplasia that is both immunogenic and immunosensitive, and undergoes complete regression after progressive growth in about 20 percent of tumor hosts by a primary lymphocyte-mediated immune rejection reaction. Moreover, host resistance of MC1-immunized mice can be adoptively transferred to untreated mice using washed lymphocytes of the spleen, lymph node or blood. The ability to cultivate the MC1 tumor as a single-cell suspension and to propagate IL 2-dependent syngeneic T cells enables further definition in vitro of this host-versus-tumor model. This study will define the effect of intratumor administration of IL-2 on MC1 tumor growth in MC1-immunized and untreated mice, and specifically the influence of IL-2 on cytolytic activity of T cells present in a large peri-tumor leukocyte population that accumulates during tumor regression. The effect of IL-2 will be defined in sequential studies that will include histopathological and morphometric analyses; phenotypic characterization of different leukocyte subsets, particularly IL-2 receptor bearing T cells as defined using [35S]-methionine radiolabelled recombinant IL-2; and functional analyses of lymphocyte-mediated anti-MC1 cytolytic activity as defined in vitro using microcytotoxicity tests and in vivo with Winn-type tumor neutralization assays. IL-2 evaluated in these studies will be derived from different sources, including: (a) human recombinant IL-2 from E. coli; (b) selected high IL-2-producing monoclones of long-term T cell lines of mice (EL-4), ape (MLA-144) and human (Jurkat J6.2); and (c) mitogen-activated normal mouse splenic leukocytes. IL-2 will be purified using anti-IL-2 monoclonal antibody affinity chromatography and reverse-phase high performance liquid chromatography.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA038842-02
Application #
3177207
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1985-04-01
Project End
1988-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
New York State Department of Health
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Streck, R J; Hurley, E L; Pauly, J L (1991) Expression and capping of a proliferation-associated surface membrane p34 kDa antigen on different human hematopoietic cell lines. J Leukoc Biol 50:182-91
Helinski, E H; Hurley, E L; Streck, R J et al. (1990) Tumor-cytolytic human macrophages cultured as nonadherent cells: potential for the adoptive immunotherapy of cancer. Cancer Detect Prev 14:471-81
Streck, R J; Helinski, E H; Ovak, G M et al. (1990) Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy. J Leukoc Biol 48:237-46
Helinski, E H; Bootsma, G H; McGroarty, R J et al. (1990) Scanning electron microscopic study of immunogold-labeled human leukocytes. J Electron Microsc Tech 14:298-306
Mookerjee, B K; Pauly, J L (1990) Mitogenic effect of interleukin-2 on unstimulated human T cells: an editorial review. J Clin Lab Anal 4:138-49
Helinski, E H; Bielat, K L; Ovak, G M et al. (1988) Long-term cultivation of functional human macrophages in Teflon dishes with serum-free media. J Leukoc Biol 44:111-21
Lee, T P; Mookerjee, B K; Pauly, J L (1988) A simple radioimmunoassay of human interleukin-2. J Immunoassay 9:193-206
Helinski, E H; Bielat, K L; Ovak, G M et al. (1988) Identification of the interleukin-2 receptor (IL-2R) on human leukemic T cells using colloidal gold and scanning electron microscopy. J Med 19:353-68
Rizzo, A G; Ovak, G M; Donovan, R M et al. (1987) Activation and long-term proliferation of human cord blood T cells with human recombinant interleukin-2. J Clin Lab Immunol 24:1-9
Pauly, J L; Bankert, R B; Repasky, E A (1986) Immunofluorescent patterns of spectrin in lymphocyte cell lines. J Immunol 136:246-53

Showing the most recent 10 out of 13 publications